•
Mar 31, 2021

Acadia Healthcare Q1 2021 Earnings Report

Acadia Healthcare reported strong first quarter results, driven by revenue growth and strategic investments.

Key Takeaways

Acadia Healthcare reported a strong start to 2021, with revenue increasing by 8.2% to $551.2 million. The company's same facility revenue grew by 7.4%, and adjusted EBITDA was $119.5 million. Acadia is focused on strategic investments in facility expansions, de novo facilities, and joint venture partnerships to drive long-term growth.

Revenue increased by 8.2% to $551.2 million compared to Q1 2020.

Same facility revenue grew by 7.4% compared to Q1 2020.

Adjusted EBITDA was $119.5 million, compared to $96.7 million in the same period last year.

The company completed debt refinancing actions in March 2021.

Total Revenue
$551M
Previous year: $783M
-29.6%
EPS
$0.47
Previous year: $0.42
+11.9%
US Same Facility Revenue Growth
7.4%
Previous year: 4.1%
+80.5%
US Same Facility Patient Days Growth
2.7%
Previous year: 2.9%
-6.9%
US Rev. per Patient Day Growth
4.5%
Previous year: 1.2%
+275.0%
Gross Profit
$226M
Previous year: $311M
-27.4%
Cash and Equivalents
$179M
Previous year: $81M
+120.9%
Free Cash Flow
$17.4M
Previous year: -$12.9M
-234.7%
Total Assets
$4.53B
Previous year: $6.72B
-32.6%

Acadia Healthcare

Acadia Healthcare

Forward Guidance

Acadia increased its financial guidance for 2021.

Positive Outlook

  • Revenue in a range of $2.24 billion to $2.29 billion
  • Adjusted EBITDA in a range of $500 million to $530 million
  • Adjusted earnings per diluted share in a range of $2.30 to $2.55
  • Interest expense of approximately $17 million per quarter for the remainder of 2021